Bacteriostatic Water

Identity and composition

Bacteriostatic Water for Injection (USP) is a sterile solution of water for injection (H2O, CAS 7732-18-5) containing 0.9% w/v (9 mg/mL) benzyl alcohol as a bacteriostatic agent. It is the standard and most general-purpose diluent for reconstituting lyophilized research peptides. The feature that distinguishes it from plain sterile water is benzyl alcohol, a preservative that inhibits bacterial growth and allows the vial to be punctured multiple times (multidose use) while maintaining sterility for approximately 28 days after the first withdrawal, when kept refrigerated. The 30 mL vial is the highest-yield presentation, intended for those who reconstitute several peptides or perform multiple preparations, since it lowers the cost per milliliter compared with small vials. EXOMA offers 30 mL bacteriostatic water at a competitive price in the Mexican market, as part of a price-leadership policy that aims to be the most economical option without sacrificing quality. It is distributed as a sterile reagent for research use (RUO).

Mechanism of action

The function of bacteriostatic water is based on two components: water for injection, which acts as the vehicle for dissolving the lyophilized peptide, and 0.9% benzyl alcohol, which provides the bacteriostatic action. Benzyl alcohol interferes with the bacterial cell membrane and with essential metabolic processes, inhibiting the proliferation of microorganisms that could be introduced during repeated punctures of the vial. This property is what enables multidose use: unlike single-use sterile water, the vial of bacteriostatic water can be used to prepare and withdraw on several occasions over days or weeks without compromising sterility. In reconstitution, the water is added onto the lyophilized powder and solubilizes the peptide in a medium of approximately neutral pH, a condition suitable for most peptides; only those with solubility or aggregation problems at neutral pH instead require an acidic diluent such as 0.6% acetic acid.

Pharmacokinetics

Bacteriostatic water is a diluent, not an active ingredient, and therefore has no pharmacokinetics of its own: its role is limited to carrying the peptide during preparation of the solution. Once the peptide is reconstituted, it is the peptide's pharmacokinetics that determine the behavior of the preparation. The benzyl alcohol present as a preservative is metabolized as a simple compound and, at concentrations of 0.9% and in the small volumes used in reconstitution, contributes no relevant systemic effects in the research context. Characterization of bacteriostatic water therefore focuses on physicochemical and microbiological quality parameters—sterility, pH, benzyl alcohol content, absence of particles and of pyrogens—rather than on pharmacokinetic variables.

Scientific evidence

Bacteriostatic water with 0.9% benzyl alcohol is a pharmacopeial (USP) diluent in consolidated use for decades for the reconstitution of lyophilized drugs and peptides that require a multi-dose vehicle. The evidence for its suitability comes from pharmaceutical and laboratory practice: it is the standard against which other diluents are compared, and most research-peptide handling protocols specify it as the default vehicle. The benzyl alcohol preservative has a long history of use as a bacteriostatic agent in injectable preparations. Within the research-use-only (RUO) framework, bacteriostatic water is provided as a preparation reagent; it is not a therapeutic product. Its proven role as a multi-dose diluent, together with a leading price-to-quality ratio in the Mexican market, make it the essential complement to any work with lyophilized peptides.

Research applications

Bacteriostatic water is the most widely used diluent in peptide research: it is used to reconstitute virtually all lyophilized peptides that are soluble and stable at neutral pH, including BPC-157, TB-500, the GHRH/GHRP secretagogues (CJC-1295, Ipamorelin), the GLP-1 analogs (semaglutide, tirzepatide, retatrutide) and most of the catalog. The 30 mL vial is especially useful when handling several compounds or performing repeated preparations, since its volume and multidose format optimize yield and minimize the cost per reconstitution. An alternative diluent —0.6% acetic acid— is used only for peptides that require acidic pH, such as IGF-1 analogs. As the highest-consumption reagent on the workbench, having quality bacteriostatic water at a competitive price has a direct impact on the total cost of research.

Safety profile

Bacteriostatic water with 0.9% benzyl alcohol is a diluent that is safe to handle in the laboratory at the usual reconstitution concentrations and volumes. The best-known safety consideration of its preservative is that benzyl alcohol is not recommended in neonatal populations and that there are volume limits in clinical use due to the total benzyl alcohol load; these warnings belong to the clinical sphere and are cited here solely for informational purposes, since this material is a research reagent (RUO). In laboratory handling, good practices of sterility and reagent manipulation are maintained. The safety information is provided for scientific and experimental-preparation purposes, not as guidance for clinical use.

Comparative context

Bacteriostatic water stands as the reference and general-purpose diluent compared with the alternatives. Compared with single-use sterile water for injection —which lacks a preservative and must be discarded after the first withdrawal—, bacteriostatic water provides the benzyl alcohol that enables multidose use, much more practical and economical when several preparations are made. Compared with 0.6% acetic acid, which is the specialized acidic-pH vehicle for peptides that aggregate in neutral medium (such as IGF-1 analogs), bacteriostatic water is the default neutral vehicle for the vast majority of peptides. The practical rule is simple: bacteriostatic water as the first option, and acetic acid only when the peptide's data sheet specifies an acidic diluent. In the 30 mL vial, and at a market-leading price in Mexico, bacteriostatic water offers the best combination of yield, practicality, and cost per milliliter of the peptide workbench.

History and development

Bacteriostatic water for injection is a pharmacopeial preparation established for decades, incorporated into the USP as a sterile multidose vehicle for the reconstitution and dilution of lyophilized medications. The addition of 0.9% benzyl alcohol as a bacteriostatic agent solved the limitation of single-use sterile water, allowing a single vial to be used across several preparations without compromising sterility, which made it the standard diluent of pharmaceutical practice and, by extension, of research peptide handling. Its 0.9% benzyl alcohol formulation and its multidose vial presentation, such as the 30 mL one, derive directly from that pharmacopeial tradition. Today it is the highest-consumption reconstitution reagent in peptide work, and having it with controlled quality at a competitive price is a logistical and economic advantage for any laboratory.

FAQ

Customer reviews

Average rating: 4.9 out of 5, based on 31 customer ratings.

Certificate of analysis per batch

Bacteriostatic Water batches with certificate of analysis published in the COA catalog:

• Lot EXO010626123A — 30 mL, issued 2026-06-01
• Lot EXO010626123B — 10 mL, issued 2026-06-01
• Lot EXO010626123C — 3 mL, issued 2026-06-01

Guides and articles about Bacteriostatic Water

Lecturas del blog de EXOMA que la editorial asoció a este compuesto:

• Bacteriostatic Water vs Sterile Water: Technical Differences
• How to Reconstitute Retatrutide 10 mg: Step-by-Step Guide
• How to Buy Peptides in Mexico Safely: Complete Guide [2026]

Other related research peptides

• Acetic acid 0.6%